XOMA Corporation Investor Relations Material

XOMA Corporation is a biotechnology company that operates primarily as a royalty aggregator. The company focuses on acquiring the economic rights to potential milestone and royalty payments associated with pre-commercial and commercial-stage therapeutic candidates. XOMA's strategy involves building a diversified portfolio of royalty interests in drugs being developed by other pharmaceutical and biotech companies. This approach allows the company to mitigate risk by spreading its investments across multiple therapeutic areas and stages of development, without bearing the costs of research and development itself. The company is headquartered in Emeryville, California, and its share are listed on the NASDAQ.